Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Clin Oral Investig ; 22(5): 1945-1951, 2018 Jun.
Article En | MEDLINE | ID: mdl-29189950

OBJECTIVES: Ventilator-associated pneumonia (VAP) is the most frequent hospital-acquired infections in intensive care units (ICU). In the bundle of care to prevent the VAP, the oral care is very important strategies, to decrease the oropharyngeal bacterial colonization and presence of causative bacteria of VAP. In view of the paucity of medical economics studies, our objective was to determine the cost of implementing this oral care program for preventing VAP. MATERIALS AND METHODS: In five ICUs, during period 1, caregivers used a foam stick for oral care and, during period 2, a stick and tooth brushing with aspiration. Budgetary effect of the new program from the hospital's point of view was analyzed for both periods. The costs avoided were calculated from the incidence density of VAP (cases per 1000 days of intubation). The cost study included device cost, benefit lost, and ICU cost (medication, employer and employee contributions, blood sample analysis…). RESULTS: A total of 2030 intubated patients admitted to the ICUs benefited from oral care. The cost of implementing the study protocol was estimated to be €11,500 per year. VAP rates decreased significantly between the two periods (p1 = 12.8% and p2 = 8.5%, p = 0.002). The VAP revenue was ranged from €28,000 to €45,000 and the average cost from €39,906 to €42,332. The total cost assessment calculated was thus around €1.9 million in favor of the new oral care program. CONCLUSION AND CLINICAL RELEVANCE: Our study showed that the implementation of a simple strategy improved the quality of patient care is economically viable. TRIAL REGISTRATION: NCT02400294.


Cross Infection/prevention & control , Infection Control/methods , Intensive Care Units , Oral Hygiene/methods , Pneumonia, Ventilator-Associated/prevention & control , Costs and Cost Analysis , Cross Infection/economics , Humans , Infection Control/economics , Oral Hygiene/economics , Pneumonia, Ventilator-Associated/economics , Treatment Outcome
2.
Fertil Steril ; 98(5): 1271-6.e1-3, 2012 Nov.
Article En | MEDLINE | ID: mdl-22818285

OBJECTIVE: To assess the reproductive outcome after an ectopic pregnancy (EP) based on the type of treatment used, and to identify predictive factors of spontaneous fertility. DESIGN: Observational population based-study. SETTING: Regional sistry. PATIENT(S): One thousand sixty-four women registered from 1992 to 2008. INTERVENTION(S): Laparoscopic (radical or conservative), or medical treatment. MAIN OUTCOME MEASURE(S): Epidemiologic characteristics, clinical presentation, treatments performed, reproductive outcome, recurrence. RESULT(S): The 24-month cumulative rate of intrauterine pregnancy (IUP) was 67% after salpingectomy, 76% after salpingostomy, and 76% after medical treatment. IUP rate was lower after radical treatment compared with conservative treatments in univariable analysis. In multivariate analysis, IUP rate was significantly lower for patients >35 years old or with history of infertility or tubal disease. For them, IUP rate was significantly higher after conservative treatment compared with salpingectomy. The 2-year cumulative rate of recurrences was 18.5% after salpingostomy or salpingectomy and 25.5% after medical treatment. History of infertility or of previous live birth would be protective, in contrast to history of voluntary termination of pregnancy. CONCLUSION(S): Conservative strategy seems to be preferred, whenever possible, to preserve patients' fertility without increasing the risk of recurrence. The choice between conservative treatments does not rely on subsequent fertility, but more likely on their own indications and therapeutic effectiveness. Risk factors of recurrence could be considered for secondary prevention.


Fertility , Pregnancy, Ectopic/epidemiology , Abortifacient Agents, Nonsteroidal/therapeutic use , Abortion, Spontaneous/epidemiology , Abortion, Therapeutic , Female , France/epidemiology , Humans , Kaplan-Meier Estimate , Laparoscopy , Live Birth , Methotrexate/therapeutic use , Multivariate Analysis , Pregnancy , Pregnancy, Ectopic/physiopathology , Pregnancy, Ectopic/therapy , Proportional Hazards Models , Recurrence , Registries , Risk Assessment , Risk Factors , Salpingectomy , Salpingostomy , Time Factors , Time-to-Pregnancy , Treatment Outcome
...